Home LiteratureArticle Details
PMID: 11442313 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Impairment of the ryanodine-sensitive calcium release channels in the cardiac sarcoplasmic reticulum and its underlying mechanism during the hypodynamic phase of sepsis.

Shock (Augusta, Ga.) ·Vol. 16 ·No. 1 ·2001-07-00 ·Pages 33-9

Dong LW, Wu LL, Ji Y, Liu MS

Abstract

Changes in Ca2+-induced Ca2+ release in cardiac sarcoplasmic reticulum (SR) during different phases of sepsis were studied. Sepsis was induced by cecal ligation and puncture (CLP). The 45Ca2+ release studies show that the amount of Ca2+ released from the passively and the actively loaded SR vesicles was unaffected during the early sepsis (9 h after CLP), but it was significantly decreased during the late phase (18 h after CLP) of sepsis. The [3H]ryanodine binding assays reveal that the Bmax for ryanodine binding was unaffected during the early phase, but was decreased by 32.1% during the late phase of sepsis. The affinity of ryanodine receptor for Ca2+ remained unchanged during sepsis. ATP, AMP-PCP, and caffeine stimulated binding, while MgCl2 and ruthenium red inhibited [3H]ryanodine binding in control, early sepsis, and late sepsis groups. The EC50 and IC50 values for these regulators were unaffected during the progression of sepsis. Digestion of control SR with phospholipase A2 decreased [3H]ryanodine binding and the decrease was reversible by the addition of phosphatidylcholine (PC), phosphatidylethanolamine (PE), or phosphatidylserine (PS). Addition of PC, PE, or PS to the SR isolated from septic rats stimulated [3H]ryanodine binding. These data demonstrate that Ca2+-induced Ca2+ release from cardiac SR remained relatively unaffected during the early phase, but was significantly impaired during the late phase of sepsis. The sepsis-induced impairment in SR Ca2+ release is a result of a quantitative reduction in the number of Ca2+ release channels. Furthermore, the reduction is associated with a mechanism involving a modification of membrane lipid profile in response to certain stimuli such as activation of phospholipase A2.

MeSH Terms
Adenosine Triphosphate/metabolism,pharmacology Animals Caffeine/pharmacology Calcium/metabolism Calcium-Transporting ATPases/metabolism Inhibitory Concentration 50 Magnesium Chloride/pharmacology Male Membrane Lipids/metabolism Myocardium/metabolism Phosphatidylcholines/metabolism,pharmacology Phosphatidylethanolamines/metabolism,pharmacology Phosphatidylserines/metabolism,pharmacology Phospholipases A/metabolism Phospholipases A2 Phospholipids/metabolism Rats Rats, Sprague-Dawley Ryanodine/metabolism Ryanodine Receptor Calcium Release Channel/metabolism Sarcoplasmic Reticulum/metabolism Sepsis/drug therapy,metabolism,physiopathology
Chemicals
Membrane Lipids Phosphatidylcholines Phosphatidylethanolamines Phosphatidylserines Phospholipids Ryanodine Receptor Calcium Release Channel Magnesium Chloride Ryanodine Caffeine Adenosine Triphosphate Phospholipases A Phospholipases A2 Calcium-Transporting ATPases Calcium
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Dong L W
Department of Pharmacological and Physiological Science, Saint Louis University School of Medicine, Missouri 63104, USA.
Wu L L
Ji Y
Liu M S
Article Info
Journal
Shock (Augusta, Ga.)
Abbr.
Shock
ISSN
1073-2322
Published
2001-07-00
Pages
33-9
Language
English
Region
United States
NLM ID
9421564
Subset
IM
Grants
NIGMS NIH HHS · GM-31664 · United States
NHLBI NIH HHS · HL-30080 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]